These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 867427)

  • 21. Formation of N-(5-nitro-2-thiazolyl)-N'-carboxymethylurea from 5-hydroxyniridazole. Role of aldehyde dehydrogenase in the oxidative metabolism of niridazole.
    Tracy JW; Catto BA; Webster LT
    Drug Metab Dispos; 1991; 19(2):508-15. PubMed ID: 1676663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the rate of formation of nitrosomorpholine from morpholine and nitrite: acceleration by thiocyanate and other anions.
    Fan TY; Tannenbaum SR
    J Agric Food Chem; 1973; 21(2):237-40. PubMed ID: 4688910
    [No Abstract]   [Full Text] [Related]  

  • 23. [NO-release ability and DNA-damage activity of aromatic N-nitroso compounds].
    Tanno M; Sueyoshi S; Fukuhara K; Miyata N; Okuda H
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2004; (122):10-5. PubMed ID: 15940896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrosation of benzoxazolinone.
    Baker JK
    Bull Environ Contam Toxicol; 1976 Dec; 16(6):743-5. PubMed ID: 1016763
    [No Abstract]   [Full Text] [Related]  

  • 25. [The role of nitro groups in the antiedemic action of butyric acid derivatives and their esters].
    Ladinskaia MIu
    Biull Eksp Biol Med; 1968 Jan; 65(1):69-72. PubMed ID: 5652292
    [No Abstract]   [Full Text] [Related]  

  • 26. A screening procedure for the formation of nitroso derivatives and mutagens by drug-nitrite interaction.
    Takeda Y; Kanaya H
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3399-404. PubMed ID: 6756658
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxicology of N-nitroso compounds.
    Shank RC
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):361-8. PubMed ID: 1096366
    [No Abstract]   [Full Text] [Related]  

  • 28. Carcinogenic effects of niridazole in rats.
    Bulay O; Clayson DB; Shubik P
    Cancer Lett; 1978 Jun; 4(6):305-10. PubMed ID: 667812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney tumors induced in rats by the antischistosomal drug niridazole.
    Bulay O; Patil K; Wilson R; Shubik P
    Cancer Res; 1979 Dec; 39(12):4996-5002. PubMed ID: 498126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental nitroso compounds: reaction of nitrite with creatine and creatinine.
    Archer MC; Clark SD; Thilly JE; Tannenbaum SR
    Science; 1971 Dec; 174(4016):1341-3. PubMed ID: 5135720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution mass spectroscopic analysis of methylated tolbutomide derivatives.
    Sabih K
    Biomed Mass Spectrom; 1974 Jun; 1(3):163-5. PubMed ID: 4433732
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection.
    Braselton WE; Bransome ED; Huff TA
    Diabetes; 1977 Jan; 26(1):50-7. PubMed ID: 830565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism.
    Schmähl D; Habs M
    Oncology; 1980; 37(4):237-42. PubMed ID: 6777721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of carcinogenicity of N-nitroso compounds by the SIMCA method of pattern recognition.
    Dunn WJ; Wold S
    J Chem Inf Comput Sci; 1981 Feb; 21(1):8-13. PubMed ID: 7240353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A contribution to the identification of the oral antidiabetic agent tolbutamide. 1st communication].
    Oelschläger H; Blume H
    Arzneimittelforschung; 1976; 26(3):303-12. PubMed ID: 989317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicogenetics of niridazole in inbred mice.
    Blumer JL; Simpson JM; Lucas SV; Webster LT
    J Pharmacol Exp Ther; 1980 Mar; 212(3):509-13. PubMed ID: 7359350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appendix: general considerations on N-nitrosatable pesticides.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jan; 30():359-406. PubMed ID: 6578189
    [No Abstract]   [Full Text] [Related]  

  • 38. A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.
    Washio K; Makaya O; Sasaki H; Nishida K; Nakamura J; Shibasaki J
    J Pharm Pharmacol; 1993 Mar; 45(3):231-3. PubMed ID: 8483106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenesis and mutagenesis by N-nitroso compounds having a basic center.
    Lijinsky W; Kovatch RM; Saavedra JE
    Cancer Lett; 1992 Apr; 63(2):101-7. PubMed ID: 1562986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the metabolic activation of the carcinogen N-hydroxy-N-2-acetylaminofluorene. 3. Oxidation with horseradish peroxidase to yield 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene.
    Bartsch H; Hecker E
    Biochim Biophys Acta; 1971 Jun; 237(3):567-78. PubMed ID: 4330271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.